Teva Replaces Generic Drugs Head in Surprise Move, Stock Drops 5.6 Percent

Dipankar Bhattacharjee, who has served as CEO of Teva Generics Europe since April 2013, will replace Siggi Olafsson, who will retire at the end of the first quarter of 2017.

Yoram Gabison
Reuters
Send in e-mailSend in e-mail
Teva's headquarters in Jerusalem.
Teva's headquarters in Jerusalem.Credit: Bloomberg
Yoram Gabison
Reuters

Comments